TAMH
LEGN icon

Taikang Asset Management (HK)’s Legend Biotech LEGN Stock Holding History

Taikang Asset Management (HK)’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-100,475
Closed -$3.41M – 105
2025
Q1 		$3.41M Hold
100,475
– – 0.46% 66
2024
Q4 		$3.27M Buy
100,475
+52,145
+108% +$2.16M 0.48% 62
2024
Q3 		$2.36M Buy
+48,330
New +$2.57M 0.25% 81
2020
Q4 		– Sell
-263,903
Closed -$8.15M – 79
2020
Q3 		$8.15M Sell
263,903
-13,839
-5% -$466K 1.26% 17
2020
Q2 		$11.8M Buy
+277,742
New +$10.9M 2.1% 15

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Taikang Asset Management (HK)'s LEGN Position: Q2 2025 in Review

Taikang Asset Management (HK) sold out of Legend Biotech (LEGN) in Q2 2025, closing a stake of 100,475 shares — an estimated $3.41M sold.

Taikang Asset Management (HK) first reported a position in LEGN in Q2 2020 and held it in 5 quarters. The position peaked at $11.8M in Q2 2020. 211 funds tracked by Wall St. Rank hold LEGN as of Q2 2025.

  • Taikang Asset Management (HK) reported no remaining Legend Biotech position as of Q2 2025 after selling out during the quarter.
  • Taikang Asset Management (HK) sold 100,475 Legend Biotech shares in Q2 2025, an estimated $3.41M.
  • Taikang Asset Management (HK) first reported a position in Legend Biotech in Q2 2020 and held it in 5 quarters.
  • Taikang Asset Management (HK)'s Legend Biotech position peaked at $11.8M in Q2 2020.
  • 211 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2025.

Based on Taikang Asset Management (HK)'s 13F filing for Q2 2025, filed 13 Aug 2025.